<DOC>
	<DOCNO>NCT00525837</DOCNO>
	<brief_summary>This study ass whether varenicline ( chantix ) antidepressant property use addition psychiatric medication . It also assess whether varenicline improve inability feel pleasure ( i.e . anhedonia ) , well-tolerated use psychiatric medication . Enrolled patient assess improved mood , improve anhedonia , overall sense health , side effect well tobacco use 6-8 week . Medication provide free charge .</brief_summary>
	<brief_title>Study Mood Effects Varenicline ( Chantix ) Depressed Outpatient Smokers</brief_title>
	<detailed_description>Outpatient smoker depress despite current stable psychiatric medication regimen invite participate . They receive varenicline dose accord FDA-approved smoking cessation regime ; patient assess use QIDS-SR16 , snaith-hamilton anhedonia rating scale , SAFTEE clinical global improvement self-report scale clinician global improvement scale time interval . Concurrent medication , psychiatric non-psychiatric , record , vital sign ( BP , HR , weight ) tobacco use .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>1 . Meets DSMIV symptom criterion mood disorder include major depression [ unipolar bipolar ] , depressive disorder NOS , dysthymia , adjustment disorder depress mood , substanceinduced mood disorder . 2 . Failed achieve full symptom remission previous pharmacotherapy . 3 . Current tobacco user . 4 . Able give write , informed consent . 1 . Past adverse reaction varenicline . 2 . Renal failure dialysis . 3 . Current pregnancy breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>varenicline</keyword>
	<keyword>depression</keyword>
	<keyword>anhedonia</keyword>
	<keyword>smoking</keyword>
</DOC>